April 2026
The global antipsychotic drugs market size was valued at USD 19.61 billion in 2025 and is projected to cross around USD 34.86 billion by 2035 with a CAGR of 5.92%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The global pingueculum drugs market size was evaluated at USD 891.64 million in 2026 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
September 2026
The global sedative-hypnotic drugs market size was evaluated at USD 16.80 billion in 2026 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global antiepileptic drugs market size was evaluated at USD 19.02 billion in 2026 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 2.19 billion in 2026 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 141.86 billion in 2026 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
September 2026
The global immunotherapy drugs market size was valued at USD 376.22 billion in 2026 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
September 2026
The global head and neck cancer drugs market size surpassed USD 20.09 billion in 2026 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
September 2026
The global S1P receptor modulator drugs market size is estimated to hit around USD 6.96 billion by 2035 increasing from USD 3.42 billion in 2026, with a CAGR of 8.22%.
September 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.62 billion in 2026, with a CAGR of 8.04%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The global orphan drugs market size was surpass to USD 242.97 billion in 2026 and is projected to reach around USD 676.59 billion by 2035 with a CAGR of 12.07%.
September 2026
The atopic dermatitis drugs market size is calculated at USD 17.21 billion in 2026 and is projected to hit around USD 33.42 billion by 2035 with a CAGR of 7.70%.
September 2026
The global hyperlipidemia drugs market size is calculated at USD 24.80 billion in 2026 and is projected to surpass USD 35.24 billion by 2035 with a CAGR of 3.98%.
September 2026
The global pediatric drugs market size was estimated at USD 183.20 billion in 2026 and is projected to hit around USD 506.52 billion by 2035 with a CAGR of 11.99%.
September 2026
The anesthesia drugs market generated USD 7.92 billion in 2026, with prominent anesthesia drugs market companies including Envigo, JANVIER LABS, Taconic Biosciences Inc.
September 2026
The global fibrate drugs market size was valued at USD 3.70 billion in 2026 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
September 2026
The global anti-obesity drugs market size is estimated at USD 8.96 billion in 2026, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
September 2026
The omega 3 prescription drugs market size was valued at USD 1.66 billion in 2026 and is projected to hit around USD 2.93 billion by 2034 with a CAGR of 7.36%.
September 2026
The global inhalable drugs market size was valued at USD 35.44 billion in 2024 and is projected to cross around USD 65.51 billion by 2034 with a CAGR of 5.57%.
September 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
September 2026
The global atherosclerosis drugs market size is projected to hit around USD 25.07 billion by 2035, increasing from USD 18.24 billion in 2026, with a CAGR of 3.60%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com